Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 385 * ! | Tue, 8/5/2014, 2:00 PM - 3:50 PM | CC-251 | |
| Impacts of Emerging Global Clinical Trials Transparency Initiatives — Topic Contributed Papers | |||
| Biopharmaceutical Section , Section on Medical Devices and Diagnostics | |||
| Organizer(s): Theodore Lystig, Medtronic | |||
| Chair(s): Estelle Russek-Cohen, FDA/CBER | |||
| 2:05 PM | When Is Data Transparency Useful? — Michael Hale, Amgen | ||
| 2:25 PM | Learning to Share: Challenges in the Implementation of Data Sharing — Jonathan Hartzel, Merck | ||
| 2:45 PM | Clinical Study Patient-Level Data Sharing: The GSK Experience to Date — Amit Bhattacharyya, GlaxoSmithKline ; Paul McSorley, GlaxoSmithKline | ||
| 3:05 PM | Voluntary Disclosure of High-Profile Clinical Trial Data: The Infuse Example — Theodore Lystig, Medtronic | ||
| 3:25 PM | Sharing Clinical Trial Data: Recent Experience and Issues Raised — Jesse Berlin, Johnson & Johnson | ||
| 3:45 PM | Floor Discussion | ||
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.